Hexose-6-phosphate Dehydrogenase Modulates 11β-Hydroxysteroid Dehydrogenase Type 1-Dependent Metabolism of 7-keto- and 7β-hydroxy-neurosteroids

被引:35
|
作者
Nashev, Lyubomir G. [1 ,2 ]
Chandsawangbhuwana, Charlie [3 ]
Balazs, Zoltan [1 ,2 ]
Atanasov, Atanas G. [4 ]
Dick, Bernhard [2 ]
Frey, Felix J. [2 ]
Baker, Michael E. [3 ]
Odermatt, Alex [1 ,2 ]
机构
[1] Univ Basel, Inst Mol & Syst Toxicol, Basel, Switzerland
[2] Univ Bern, Dept Hypertens & Nephrol, Bern, Switzerland
[3] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[4] Univ Bern, Inst Pathol, Div Immunopathol, Bern, Switzerland
来源
PLOS ONE | 2007年 / 2卷 / 06期
基金
瑞士国家科学基金会;
关键词
D O I
10.1371/journal.pone.0000561
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. The role of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) in the regulation of energy metabolism and immune system by locally reactivating glucocorticoids has been extensively studied. Experiments determining initial rates of enzyme activity revealed that 11 beta-HSD1 can catalyze both the reductase and the dehydrogenase reaction in cell lysates, whereas it predominantly catalyzes the reduction of cortisone to cortisol in intact cells that also express hexose-6-phosphate dehydrogenase (H6PDH), which provides cofactor NADPH. Besides its role in glucocorticoid metabolism, there is evidence that 11 beta-HSD1 is involved in the metabolism of 7-keto- and 7-hydroxy-steroids; however the impact of H6PDH on this alternative function of 11 beta-HSD1 has not been assessed. Methodology. We investigated the 11 beta-HSD1-dependent metabolism of the neurosteroids 7-keto-, 7 alpha-hydroxy- and 7 beta-hydroxy-dehydroepiandrosterone ( DHEA) and 7-keto- and 7 beta-hydroxy-pregnenolone, respectively, in the absence or presence of H6PDH in intact cells. 3D-structural modeling was applied to study the binding of ligands in 11 beta-HSD1. Principal Findings. We demonstrated that 11 beta-HSD1 functions in a reversible way and efficiently catalyzed the interconversion of these 7-keto- and 7-hydroxy-neurosteroids in intact cells. In the presence of H6PDH, 11 beta-HSD1 predominantly converted 7-keto-DHEA and 7-ketopregnenolone into their corresponding 7 beta-hydroxy metabolites, indicating a role for H6PDH and 11 beta-HSD1 in the local generation of 7 beta-hydroxy-neurosteroids. 3D-structural modeling offered an explanation for the preferred formation of 7-hydroxy-neurosteroids. Conclusions. Our results from experiments determining the steady state concentrations of glucocorticoids or 7-oxygenated neurosteroids suggested that the equilibrium between cortisone and cortisol and between 7-keto- and 7-hydroxy-neurosteroids is regulated by 11 beta-HSD1 and greatly depends on the coexpression with H6PDH. Thus, the impact of H6PDH on 11 beta-HSD1 activity has to be considered for understanding both glucocorticoid and neurosteroid action in different tissues.
引用
收藏
页数:9
相关论文
共 46 条
  • [41] Synthesis and Biological Evaluation of (6-and 7-Phenyl) Coumarin Derivatives as Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1
    Starcevic, Stefan
    Brozic, Petra
    Turk, Samo
    Cesar, Jozko
    Rizner, Tea Lanisnik
    Gobec, Stanislav
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 248 - 261
  • [42] 11β-hydroxysteroid dehydrogenase type 1 regulation by intracellular glucose 6-phosphate provides evidence for a novel link between glucose metabolism and Hypothalamo-Pituitary-Adrenal axis function
    Walker, Elizabeth A.
    Ahmed, Adeeba
    Lavery, Gareth G.
    Tomlinson, Jeremy W.
    Kim, So Youn
    Cooper, Mark S.
    Ride, Jonathan P.
    Hughes, Beverly A.
    Shackleton, Cedric H. L.
    McKiernan, Patrick
    Elias, Elwyn
    Chou, Janice Y.
    Stewart, Paul M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (37) : 27030 - 27036
  • [43] Insulin-like growth factor (IGF)-I represses 11β-HSD1 activity via regulation of hexose-6-phosphate dehydrogenase (H6PDH) mRNA in 3T3-L1 adipocytes
    Ishikawa, Yukiko
    Morita, Junko
    Hizuka, Naomi
    Fukuda, Izumi
    Hakuno, Fumihiko
    Takahashi, Shin-Ichiro
    Takano, Kazue
    ENDOCRINE JOURNAL, 2010, 57 : S519 - S519
  • [44] Characterization of estrogen-dependent growth of cultured MCF-7 human breast-cancer cells expressing 17 beta-hydroxysteroid dehydrogenase type 1
    Miettinen, MM
    Poutanen, MH
    Vihko, RK
    INTERNATIONAL JOURNAL OF CANCER, 1996, 68 (05) : 600 - 604
  • [45] N-butyl-N-methyl-11-(3′-hydroxy-21′,17′-carbolactone-19′-nor-17′α-pregna-1′,3′,5′(10′)-trien-7′α-yl)-undecanamide:: an inhibitor of type 2 17β-hydroxysteroid dehydrogenase that does not have oestrogenic or androgenic activity
    Sam, KM
    Labrie, F
    Poirier, D
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (02) : 217 - 225
  • [46] Discovery of 2-((R)-4-(2-Fluoro-4-(methylsulfonyl)phenyl)-2-methylpiperazin-1-yl)-N-((1R,2s,3S,5S,7S)-5-hydroxyadamantan-2-y1)pyrimidine-4-carboxamide (SKI2852): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
    Ryu, Je Ho
    Lee, Jung A.
    Kim, Shinae
    Shin, Young Ah
    Yang, Jewon
    Han, Hye Young
    Son, Hyun Joo
    Kim, Yong Hyuk
    Sa, Joon Ho
    Kim, Jae-Sun
    Lee, Jungeun
    Lee, Jeeyeon
    Park, Hyeung-geun
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (22) : 10176 - 10189